Evolution News and Research

RSS

New ASH report outlines several models for 'systems-based clinical hematologist'

A report released today from the American Society of Hematology in its journal, Blood, presents an innovative, sustainable new role for hematologists, particularly those specializing in non-malignant blood diseases, for today’s rapidly changing U.S. health-care system.

9 Mar 2015

Adults only really catch flu about twice a decade, suggests study

Adults over the age of 30 only catch flu about twice a decade, a new study suggests. Flu-like illness can be caused by many pathogens, making it difficult to assess how often people are infected by influenza.

6 Mar 2015

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model

For the first time, CRISPR-Cas9 gene-editing technology has been employed in a whole organism model to systematically target every gene in the genome.

6 Mar 2015

Babies treated for CMV infection for six months have better developmental outcomes

Babies treated for symptomatic cytomegalovirus (CMV) infection for six months, instead of the standard six weeks, have better hearing and developmental outcomes, according to a new study from the University of Alabama at Birmingham.

5 Mar 2015

Resverlogix, Emerald Logic complete collaborative research program

Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.

4 Mar 2015

Researchers find new retrovirus 'fossil' in vampire bats

Scientists discovered a new retrovirus "fossil" found in the common vampire bat which is homologous to retroviruses in rodents and primates. The results suggest the recent circulation of an active infectious retrovirus and cross-species transmission.

4 Mar 2015

Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

Endo International plc today reported fourth quarter 2014 revenues of $800 million, an increase of 37 percent compared to fourth quarter 2013 revenues of $585 million, including new product revenue from 2014 strategic M&A transactions.

2 Mar 2015

Qualcomm launches Snapdragon Sense ID 3D Fingerprint Technology

Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, is extending its mobile security leadership with the launch of Qualcomm Snapdragon Sense ID 3D Fingerprint Technology, the mobile industry's first 3D fingerprint authentication technology based on ultrasonic technology.

2 Mar 2015

New book provides in-depth, advanced understanding of Ebola and rabies viruses

Significant human and animal pathogens remain major scourges to human health. Recent devastating Ebola virus disease outbreak in West Africa underscores the importance of understanding the biology of replication and response of host cells to infection by these pathogens.

28 Feb 2015

Drosophila Research Conference to highlight recent advances in genetics research

Over 1,500 scientists from 30 countries and 46 states will attend next week's 56th Annual Drosophila Research Conference organized by the Genetics Society of America, March 4–8 in Chicago, IL.

28 Feb 2015

Single-step fermentative method may facilitate industrial-scale statin drug production

University of Manchester researchers, together with industrial partner DSM, have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production.

27 Feb 2015

Researchers reveal that mosquitoes’ sexual biology may key to malaria transmission

Sexual biology may be the key to uncovering why Anopheles mosquitoes are unique in their ability to transmit malaria to humans, according to researchers at Harvard T. H. Chan School of Public Health and University of Perugia, Italy.

27 Feb 2015

MIT researchers devise new way to make complex emulsions

MIT researchers have devised a new way to make complex liquid mixtures, known as emulsions, that could have many applications in drug delivery, sensing, cleaning up pollutants, and performing chemical reactions.

27 Feb 2015

Esaote introduces eXP technology-powered EVOLUTION’15 at ECR 2015

At ECR 2015 Esaote, a world leading manufacturer of medical diagnostic systems, introduces Evolution’15 (EVO’15) as the latest upgrade in its dedicated MRI Evolution program. EVO’15 combines software updates and new hardware features to provide superb image quality and increases productivity by almost 50%.

25 Feb 2015

N30 Pharmaceuticals becomes Nivalis Therapeutics

N30 Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the development of product candidates for cystic fibrosis (CF), announced today that the Company has changed its name to Nivalis Therapeutics, Inc. The Company's lead product candidate, N91115, is a novel inhibitor of S-nitrosoglutathione reductase (GSNOR).

24 Feb 2015

Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

Accuray Incorporated and Lancaster General Health announced today that the first commercially available InCise Multileaf Collimator (MLC) for the CyberKnife M6 System has been received by Lancaster.

24 Feb 2015

Study suggests that antibiotics can induce potentially dangerous biofilm formation

Most people have taken an antibiotic to treat a bacterial infection. Now researchers from the University of North Carolina at Chapel Hill and the University of San Diego, La Jolla, reveal that the way we often think about antibiotics - as straightforward killing machines - needs to be revised.

24 Feb 2015

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores).

23 Feb 2015

MD Anderson awarded more than $22 million in research grants from CPRIT

The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas. Approximately half of the funds awarded for Individual Investigator Research Awards went to MD Anderson faculty as well as 40 percent of total IIRA awards that include those for children's and adolescent cancer and early detection and prevention.

21 Feb 2015

Saluda Medical receives $10 million in Series B financing

Saluda Medical has today announced that it has received $10 million in Series B financing bringing a breakthrough treatment for chronic pain one step closer to reality.

20 Feb 2015

Evolution News and Research

New ASH report outlines several models for 'systems-based clinical hematologist'

Adults only really catch flu about twice a decade, suggests study

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model

Babies treated for CMV infection for six months have better developmental outcomes

Resverlogix, Emerald Logic complete collaborative research program

Researchers find new retrovirus 'fossil' in vampire bats

Endo International’s revenues increase $800 million to 37% in fourth quarter 2014

Qualcomm launches Snapdragon Sense ID 3D Fingerprint Technology

New book provides in-depth, advanced understanding of Ebola and rabies viruses

Drosophila Research Conference to highlight recent advances in genetics research

Single-step fermentative method may facilitate industrial-scale statin drug production

Researchers reveal that mosquitoes’ sexual biology may key to malaria transmission

MIT researchers devise new way to make complex emulsions

Esaote introduces eXP technology-powered EVOLUTION’15 at ECR 2015

N30 Pharmaceuticals becomes Nivalis Therapeutics

Accuray, Lancaster announces commercial availability of InCise MLC for CyberKnife M6 System

Study suggests that antibiotics can induce potentially dangerous biofilm formation

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

MD Anderson awarded more than $22 million in research grants from CPRIT

Saluda Medical receives $10 million in Series B financing

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News